Korus: a Device to Prevent Sudden Unexpected Death in Epilepsy (SUDEP)

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06135285
Collaborator
(none)
10
1
1
35
0.3

Study Details

Study Description

Brief Summary

The goal of this feasibility study is to test the Korus smart mattress in healthy volunteers.

The main questions it aims to answer are:
  • Can Korus accurately detect body position in bed (left, right, supine, prone)

  • Can Korus reposition the subject from a prone to recovery (sideways) position? Participants will be asked to lie down on Korus and turn into various positions; when the prone position is detected, they will be repositioned.

Condition or Disease Intervention/Treatment Phase
  • Device: Control subjects
N/A

Detailed Description

Korus is a a smart mattress consisting entirely of pneumatically inflatable smartcells with embedded sensors. It is designed to detect a subject's body position an inflate the proper smartcells to reposition a subject from the prone to the recovery (sideways) position. Healthy control subjects will be recruited to test Korus' sensing system and its performance in repositioning the subject. Korus will utilize specialized sensors and a computer learning algorithm to detect the subject's body position. Based on this data, Korus will activate the appropriate smart cells to reposition the subject.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Korus: Smart Mattress to Prevent Night-time Sudden Unexpected Death in Epilepsy (SUDEP)
Anticipated Study Start Date :
Jul 1, 2024
Anticipated Primary Completion Date :
Jun 1, 2027
Anticipated Study Completion Date :
Jun 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control subjects

The subject will lie down on the Korus smart mattress. Korus will detect when the subject is in a prone (face-down) position and reposition the subject into a recovery (sideways) position.

Device: Control subjects
The subject will be repositioned from the prone to recovery position

Outcome Measures

Primary Outcome Measures

  1. Body position detection [5 seconds]

    Correct detection of one of 4 cardinal body positions: prone, supine, left, right

  2. Number of subjects correctly repositioned from the prone to recovery position [30 seconds]

    We will measure the performance of Korus to successfully reposition the subject from the prone to recovery position

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

• Adults age 18-65; at least 30% of subjects will be self-identified as prone sleepers

Exclusion Criteria: any significant medical history for which body movements will potentially be harmful, including but not limited to:

  • History of neurological dysfunction, including spinal cord abnormalities

  • History of psychiatric disorder, including anxiety

  • History of cardiac dysfunction

  • History of osteoporosis or osteopenia

  • History of significant orthopedic dysfunction

  • History of falls

  • History of sleep disorder

  • Taking neuroactive medications

  • Taking anticoagulants

  • Current recreational drug use

  • BMI under 18 or over 30

  • Systolic BP >180 or <90

  • Open wounds

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brigham and Women's Hospital Boston Massachusetts United States 02115

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

  • Principal Investigator: Jong Woo Lee, MD, PhD, Brigham and Women's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jong Woo Lee, Associate Professor of Neurology, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT06135285
Other Study ID Numbers:
  • 2023P002023
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023